American Society of Hematology

Figure 5.

$Post-alloSCT CD146+MSC harbor reduced CFU-F capacity. (A) Presence of CFU-F in BM aspirates at pre-alloSCT (n = 19) and post-alloSCT (n = 26). (B) Proportion of CD146+MNC cells in the CD45-/HLA-DR- BM-MNC–fraction in BM aspirates of 16 patients pre- and post-alloSCT. (C) Summary of 14 patients with CD146+CFU-Fs presence, mean of CFU-Fs per 1000 sorted CD146+BM-MNC and median of CFU-Fs.$

Post-alloSCT CD146⁺MSC harbor reduced CFU-F capacity. (A) Presence of CFU-F in BM aspirates at pre-alloSCT (n = 19) and post-alloSCT (n = 26). (B) Proportion of CD146⁺MNC cells in the CD45^-/HLA-DR^- BM-MNC–fraction in BM aspirates of 16 patients pre- and post-alloSCT. (C) Summary of 14 patients with CD146⁺CFU-Fs presence, mean of CFU-Fs per 1000 sorted CD146⁺BM-MNC and median of CFU-Fs.

This Feature Is Available To Subscribers Only